Treatment-Free Remission in Ponatinib-Treated CML Patients: The Italy-Tfr Experience von Fava, Carmen, Santoro, Marco, Caramella, Marianna, Abruzzese, Elisabetta, Giai, Valentina, Cattaneo, Daniele, Elena, Chiara, Tiribelli, Mario, D'Adda, Mariella, Loglisci, Giuseppina, Bonuomo, Valentina, Grano, Selene, Ferrari, Jacqueline, Catania, Federica Maria, Pungolino, Ester Maria, Iurlo, Alessandra

Volltext

A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment... von Passamonti, Francesco, Cervantes, Francisco, Vannucchi, Alessandro Maria, Morra, Enrica, Rumi, Elisa, Pereira, Arturo, Guglielmelli, Paola, Pungolino, Ester, Caramella, Marianna, Maffioli, Margherita, Pascutto, Cristiana, Lazzarino, Mario, Cazzola, Mario, Tefferi, Ayalew

Volltext

Occult hepatitis B infection reactivation after ruxolitinib therapy von Perricone, Giovanni, Vinci, Maria, Pungolino, Ester

Volltext

Nilotinib interferes with cell cycle, ABC transporters and JAK-STAT signaling pathway in CD34+/lin- cells of patients with chronic phase chronic myeloid leukemia after 12 months of... von Trojani, Alessandra, Pungolino, Ester, Dal Molin, Alessandra, Lodola, Milena, Rossi, Giuseppe, D'Adda, Mariella, Perego, Alessandra, Elena, Chiara, Turrini, Mauro, Borin, Lorenza, Bucelli, Cristina, Malato, Simona, Carraro, Maria Cristina, Spina, Francesco, Latargia, Maria Luisa, Artale, Salvatore, Spedini, Pierangelo, Anghilieri, Michela, Di Camillo, Barbara, Baruzzo, Giacomo, De Canal, Gabriella, Iurlo, Alessandra, Morra, Enrica, Cairoli, Roberto

Volltext

Increased tumor burden in patients with chronic myeloid leukemia after 36 months of imatinib discontinuation von Diral, Elisa, Mori, Silvia, Antolini, Laura, Abruzzese, Elisabetta, Le Coutre, Philipp, Martino, Bruno, Pungolino, Ester, Elena, Chiara, Bergamaschi, Micaela, Assouline, Sarit, Di Bona, Eros, Gozzini, Antonella, Andrade-Campos, Marcio, Stagno, Fabio, Iurlo, Alessandra, Pirola, Alessandra, Fontana, Diletta, Petiti, Jessica, Bonanomi, Maria Luisa, Crivori, Patrizia, Piazza, Rocco, Fava, Carmen, Gambacorti-Passerini, Carlo

Volltext

Prognostic Factors for Malignant Transformation in Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma von Cesana, C.

Volltext

P667: RISK OF PROGRESSION IN CHRONIC PHASE‐CHRONIC MYELOID LEUKEMIA PATIENTS ELIGIBLE FOR TYROSINE KINASE INHIBITOR DISCONTINUATION: FINAL ANALYSIS OF THE TFR‐PRO STUDY von Paolo Maria Zambrotta, Giovanni, Assouline, Sarit, Nicolini, Franck E., Abruzzese, Elisabetta, Pungolino, Ester, Cristina Miggiano, Maria, Elena, Chiara, Alvarez Larran, Alberto, Triguero Moreno, Ana, Iurlo, Alessandra, Bucelli, Cristina, Lunghi, Francesca, Capodanno, Isabella, Maffioli, Margherita, Galimberti, Sara, Caocci, Giovanni, Stagno, Fabio, Saussele, Susanne, Fava, Carmen, Le Coutre, Philipp, Bonifacio, Massimiliano, Guglielmana, Veronica, Colombo, Federica, Antolinni, Laura, Gambacorti‐Passerini, Carlo

Volltext

Use of generic imatinib as first-line treatment in patients with chronic myeloid leukemia (CML): the GIMS (Glivec to Imatinib Switch) study von Gemelli, Maria, Elli, Elena Maria, Elena, Chiara, Iurlo, Alessandra, Intermesoli, Tamara, Maffioli, Margherita, Pungolino, Ester, Carraro, Maria Cristina, D'Adda, Mariella, Lunghi, Francesca, Anghileri, Michela, Polverelli, Nicola, Rossi, Marianna, Bacciocchi, Mattia, Bono, Elisa, Bucelli, Cristina, Passamonti, Francesco, Antolini, Laura, Gambacorti-Passerini, Carlo

Volltext

Risk of progression in chronic phase‐chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the TFR‐PRO study von Zambrotta, Giovanni Paolo Maria, Nicolini, Franck E., Assouline, Sarit, Busque, Lambert, Pungolino, Ester, Abruzzese, Elisabetta, Miggiano, Maria Cristina, Elena, Chiara, Alvarez‐Larran, Alberto, Triguero, Ana, Iurlo, Alessandra, Bucelli, Cristina, Cerrano, Marco, Capodanno, Isabella, Lunghi, Francesca, Coutre, Philipp, Galimberti, Sara, Caocci, Giovanni, Maffioli, Margherita, Stagno, Fabio, Saussele, Susanne, Piazza, Rocco, Druker, Brian J., Fava, Carmen, Guglielmana, Veronica, Colombo, Federica, Antolini, Laura, Gambacorti‐Passerini, Carlo

Volltext

Progressive Down Regulation of JAK-STAT, Cell Cycle, and ABC Transporter Genes in CD34+/Lin- Cells of Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients at Diagnosis Vs. 12 M... von Trojani, Alessandra, Pungolino, Ester, Rossi, Giuseppe, D'adda, Mariella, Bossi, Luca Emanuele, Baruzzo, Giacomo, Di Camillo, Barbara, Perego, Alessandra, Turrini, Mauro, Elena, Chiara, Borin, Lorenza Maria, Iurlo, Alessandra, Malato, Simona, Spina, Francesco, Latargia, Maria Luisa, Spedini, Pierangelo, Artale, Salvatore, Anghilieri, Michela, Carraro, Maria Cristina, Bucelli, Cristina, De Canal, Gabriella, Morra, Enrica, Cairoli, Roberto

Volltext

Nilotinib‐induced bone marrow CD34+/lin‐Ph+ cells early clearance in newly diagnosed CP‐Chronic Myeloid Leukemia: Final report of the PhilosoPhi34 study von Pungolino, Ester, D'adda, Mariella, De Canal, Gabriella, Trojani, Alessandra, Perego, Alessandra, Elena, Chiara, Lunghi, Francesca, Turrini, Mauro, Borin, Lorenza, Iurlo, Alessandra, Latargia, Maria Luisa, Carraro, Maria Cristina, Spina, Francesco, Artale, Salvatore, Anghilieri, Michela, Molteni, Alfredo, Caramella, Marianna, Baruzzo, Giacomo, Nichelatti, Michele, Di Camillo, Barbara, Cairoli, Roberto

Volltext

Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation von Passamonti, Francesco, Randi, Maria Luigia, Rumi, Elisa, Pungolino, Ester, Elena, Chiara, Pietra, Daniela, Scapin, Margherita, Arcaini, Luca, Tezza, Fabiana, Moratti, Remigio, Pascutto, Cristiana, Fabris, Fabrizio, Morra, Enrica, Cazzola, Mario, Lazzarino, Mario

Volltext

Preliminary Experience of Imatinib after Nilotinib in the First Line Treatment of Chronic Myeloid Leukemia von Pungolino, Ester, D'adda, Mariella, Perego, Alessandra, Orlandi, Ester Maria, Turrini, Mauro, Borin, Lorenza Maria, Iurlo, Alessandra, Artale, Salvatore, Latargia, Maria Luisa, Anghilieri, Michela, Malato, Simona, Trojani, Alessandra, Spina, Francesco, Maria Cristina, Carraro, Pioltelli, Maria Luisa, Elena, Chiara, Bucelli, Cristina, Spedini, Pierangelo, Rossi, Giuseppe, Morra, Enrica, Cairoli, Roberto

Volltext

Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter series von Iurlo, Alessandra, Galimberti, Sara, Abruzzese, Elisabetta, Annunziata, Mario, Bonifacio, Massimiliano, Latagliata, Roberto, Pregno, Patrizia, Ferrero, Dario, Sorà, Federica, Orlandi, Ester Maria, Fava, Carmen, Cattaneo, Daniele, Bucelli, Cristina, Binotto, Gianni, Pungolino, Ester, Tiribelli, Mario, Gozzini, Antonella, Gugliotta, Gabriele, Castagnetti, Fausto, Stagno, Fabio, Rege-Cambrin, Giovanna, Martino, Bruno, Luciano, Luigiana, Breccia, Massimo, Sica, Simona, Bocchia, Monica, Pane, Fabrizio, Saglio, Giuseppe, Rosti, Gianantonio, Specchia, Giorgina, Cortelezzi, Agostino, Baccarani, Michele

Volltext

Gene Expression Profiling and Cellularity of Bone Marrow CD34+/Lin- Cells of Patients with Chronic-Phase Chronic Myeloid Leukemia at Diagnosis Vs. 12 Months of First-Line Nilotinib... von Trojani, Alessandra, Pungolino, Ester, Rossi, Giuseppe, D'Adda, Mariella, Lodola, Milena, Di Camillo, Barbara, Perego, Alessandra, Turrini, Mauro, Orlandi, Ester Maria, Borin, Lorenza Maria, Iurlo, Alessandra, Malato, Simona, Spina, Francesco, Latargia, Maria Luisa, Lanza, Francesco, Artale, Salvatore, Anghilieri, Michela, Maria Cristina, Carraro, Bucelli, Cristina, De Canal, Gabriella, Morra, Enrica, Cairoli, Roberto

Volltext

Combining Imatinib-Following-Nilotinib Treatment in First Line Therapy for Chronic Phase Chronic Myeloid Leukemia. Update from the PhilosoPhi34 Study at 24 Months of Follow-up von Pioltelli, Maria Luisa, Pungolino, Ester, D'adda, Mariella, Elena, Chiara, Borin, Lorenza Maria, Perego, Alessandra, Iurlo, Alessandra, Trojani, Alessandra, Turrini, Mauro, Caramella, Marianna, Spedini, Pierangelo, Malato, Simona, Spina, Francesco, Artale, Salvatore, Carraro, Mariacristina, Orofino, Nicola, Anghilieri, Michela, Farina, Mirko, Latargia, Maria Luisa, Rossi, Giuseppe, Morra, Enrica, Cairoli, Roberto

Volltext

Nilotinib Deregulates Cell Cycle Checkpoints, ABC Transporters Genes and JAK-STAT Signaling Pathway of CD34+/Lin- Cells in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients... von Trojani, Alessandra, Pungolino, Ester, Rossi, Giuseppe, D'adda, Mariella, Lodola, Milena, Dal Molin, Alessandra, Baruzzo, Giacomo, Perego, Alessandra, Turrini, Mauro, Elena, Chiara, Borin, Lorenza Maria, Iurlo, Alessandra, Malato, Simona, Spina, Francesco, Latargia, Maria Luisa, Spedini, Pierangelo, Artale, Salvatore, Anghilieri, Michela, Maria Cristina, Carraro, Bucelli, Cristina, De Canal, Gabriella, Morra, Enrica, Cairoli, Roberto

Volltext

Nilotinib induced bone marrow CD34+/lin–Ph+ cells early clearance in newly diagnosed CP‐chronic myeloid leukemia von Pungolino, Ester, Rossi, Giuseppe, De Canal, Gabriella, Trojani, Alessandra, D'adda, Mariella, Perego, Alessandra, Orlandi, Ester Maria, Lunghi, Francesca, Turrini, Mauro, Borin, Lorenza, Iurlo, Alessandra, Latargia, Maria Luisa, Carraro, Maria Cristina, Spina, Francesco, Lodola, Milena, Artale, Salvatore, Anghilieri, Michela, Spedini, Pierangelo, Cantoni, Silvia, Di Camillo, Barbara, Morra, Enrica, Cairoli, Roberto

Volltext

Jak-2 and Nfkbia Gene Expression Play a Strategic Role in Chronic Myeloid Leukemia (CML) Molecular Response during Early Nilotinib Treatment: The PhilosoPhi34 Data von Pungolino, Ester, D'adda, Mariella, Trojani, Alessandra, Perego, Alessandra, Elena, Chiara, Iurlo, Alessandra, Malato, Simona, Turrini, Mauro, De Canal, Gabriella, Borin, Lorenza, Lodola, Milena, Caramella, Marianna, Artale, Salvatore, Spina, Francesco, Latargia, Maria Luisa, Anghilieri, Michela, Spedini, Pierangelo, Carraro, Mariacristina, Di Camillo, Barbara, Gramegna, Doriana, Pioltelli, Maria Luisa, Rossi, Giuseppe, Morra, Enrica, Cairoli, Roberto

Volltext

The REL-Protocol PhilosoPhi34 - an Open Label, Single Arm, Phase II Study of Nilotinib 300 Mg BID in Newly Diagnosed Chronic Phase Chronic Myeloid Leukaemia (CML) Patients - Confir... von Pungolino, Ester, De Canal, Gabriella, D'adda, Mariella, Perego, Alessandra, Turrini, Mauro, Orlandi, Ester Maria, Trojani, Alessandra, Borin, Lorenza, Iurlo, Alessandra, Latargia, Maria Luisa, Malato, Simona, Carraro, Maria Cristina, Brusorio, Stefania, Elena, Chiara, Spina, Francesco, Lodola, Milena, Artale, Salvatore, Anghilieri, Michela, Bucelli, Cristina, Pioltelli, Maria Luisa, Cantoni, Silvia, Rossi, Giuseppe, Morra, Enrica, Cairoli, Roberto

Volltext